Literature DB >> 24593661

miR-30b regulates migration and invasion of human colorectal cancer via SIX1.

Hui Zhao1, Zifeng Xu2, Huanlong Qin3, Zhuo Gao, Lu Gao.   

Abstract

CRC (colorectal cancer) is one of the most malignant tumours in both developing and developed countries. It is estimated that 60% of CRC patients have liver metastasis. In the present study, we show that miR-30b is an important regulator in human CRC migration and invasion, which are vital steps in CRC liver metastasis. miR-30b was significantly down-regulated in primary CRC specimens compared with normal tissues. Furthermore, miR-30b was much lower in liver metastasis tissues than in CRCs. We validated SIX1 (SIX homeobox 1), a member of the SIX homeodomain family of transcription factors and an EMT (epithelial-mesenchymal transition)-promoting gene, as the direct target of miR-30b. Forced expression of miR-30b inhibited CRC cell migration and invasion in vitro via its target gene SIX1. Furthermore, an inverse correlation between expression of SIX1 and miR-30b has been observed both in primary CRC specimens and liver metastasis. Taken together, miR-30b plays an important role in mediating metastatic related behaviour in CRC. miR-30b may serve as a potential diagnostic marker and therapeutic target for patients with CRC in the future.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24593661     DOI: 10.1042/BJ20131535

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  MARCH5 RNA promotes autophagy, migration, and invasion of ovarian cancer cells.

Authors:  Jianguo Hu; Ying Meng; Zhanqin Zhang; Qiuting Yan; Xingwei Jiang; Zilan Lv; Lina Hu
Journal:  Autophagy       Date:  2016-11-22       Impact factor: 16.016

2.  Impaired cell migration and structural defects in myeloid cells overexpressing miR-30b and miR-142-3p.

Authors:  Araceli Valverde; Salvador Nares; Afsar Raza Naqvi
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2020-09-24       Impact factor: 4.490

3.  Fucoxanthin induces apoptosis in human cervical cancer cell line HeLa via PI3K/Akt pathway.

Authors:  Guoliu Ye; Qin Lu; Weidong Zhao; Danli Du; Lijie Jin; Yusheng Liu
Journal:  Tumour Biol       Date:  2014-08-13

4.  MicroRNA-9 regulates non-small cell lung cancer cell invasion and migration by targeting eukaryotic translation initiation factor 5A2.

Authors:  Guodong Xu; Guofeng Shao; Qiaoling Pan; Lebo Sun; Dawei Zheng; Minghui Li; Ni Li; Huoshun Shi; Yiming Ni
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

5.  The PAX-SIX-EYA-DACH network modulates GATA-FOG function in fly hematopoiesis and human erythropoiesis.

Authors:  T Michael Creed; Rajkumar Baldeosingh; Christian L Eberly; Caroline S Schlee; MinJung Kim; Jevon A Cutler; Akhilesh Pandey; Curt I Civin; Nancy G Fossett; Tami J Kingsbury
Journal:  Development       Date:  2020-01-03       Impact factor: 6.868

6.  miR-30 family promotes migratory and invasive abilities in CD133(+) pancreatic cancer stem-like cells.

Authors:  Koichiro Tsukasa; Qiang Ding; Yumi Miyazaki; Shyuichiro Matsubara; Shoji Natsugoe; Sonshin Takao
Journal:  Hum Cell       Date:  2016-03-10       Impact factor: 4.174

Review 7.  The SIX1-EYA transcriptional complex as a therapeutic target in cancer.

Authors:  Melanie A Blevins; Christina G Towers; Aaron N Patrick; Rui Zhao; Heide L Ford
Journal:  Expert Opin Ther Targets       Date:  2015-01-02       Impact factor: 6.902

8.  Experimental evidences for miR-30b as a negative regulator of FOXO3 upregulated by kynurenine.

Authors:  Zhi-Qing Duan; Yan Li; Lu Li
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

9.  Influence of miR-30b regulating humoral immune response by genetic difference.

Authors:  Zhi-Qing Duan; Jian-Dong Shi; Mei-Ni Wu; Ning-Zhu Hu; Yun-Zhang Hu
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

10.  MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer.

Authors:  Shu-Bo Tian; Jian-Chun Yu; Yu-Qin Liu; Wei-Ming Kang; Zhi-Qiang Ma; Xin Ye; Chao Yan
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.